QURE – uniQure N.V.
uniQure N.V.QURE
$13.00Name : uniQure N.V.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $702,999,680.00
EPSttm : -4.92
uniQure N.V.
$13.00
38.45%$3.61Float Short %
8.88
Margin Of Safety %
Put/Call OI Ratio
0.13
EPS Next Q Diff
0.53
EPS Last/This Y
1.26
EPS This/Next Y
0.82
Price
13
Target Price
35.17
Analyst Recom
1.29
Performance Q
-8.52
Relative Volume
13.15
Beta
0.21
Ticker: QURE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | QURE | 13.74 | 0.13 | 0.31 | 37974 |
| 2025-03-24 | QURE | 14.79 | 0.14 | 0.02 | 32514 |
| 2025-03-25 | QURE | 14.38 | 0.14 | 0.15 | 33206 |
| 2025-03-26 | QURE | 13.91 | 0.14 | 0.04 | 33413 |
| 2025-03-27 | QURE | 13.12 | 0.14 | 0.43 | 33347 |
| 2025-03-28 | QURE | 12.48 | 0.19 | 0.01 | 33567 |
| 2025-03-31 | QURE | 10.61 | 0.19 | 0.39 | 32540 |
| 2025-04-01 | QURE | 9.89 | 0.19 | 0.20 | 35823 |
| 2025-04-02 | QURE | 10.63 | 0.18 | 0.02 | 35869 |
| 2025-04-03 | QURE | 9.73 | 0.18 | 0.33 | 36025 |
| 2025-04-04 | QURE | 8.95 | 0.18 | 1.80 | 36078 |
| 2025-04-07 | QURE | 8.76 | 0.18 | 0.95 | 36144 |
| 2025-04-08 | QURE | 8.34 | 0.18 | 0.55 | 36140 |
| 2025-04-09 | QURE | 9.16 | 0.19 | 0.53 | 34199 |
| 2025-04-10 | QURE | 8.55 | 0.19 | 0.00 | 34164 |
| 2025-04-11 | QURE | 8.93 | 0.17 | 0.01 | 34779 |
| 2025-04-14 | QURE | 9.29 | 0.15 | 0.53 | 38702 |
| 2025-04-15 | QURE | 9.64 | 0.15 | 0.14 | 38817 |
| 2025-04-16 | QURE | 9.41 | 0.14 | 0.33 | 48395 |
| 2025-04-17 | QURE | 12.99 | 0.13 | 1.00 | 48673 |
| 2025-04-18 | QURE | 13 | 0.13 | 1.00 | 48673 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | QURE | 13.74 | 25.0 | 84.9 | -3.64 |
| 2025-03-24 | QURE | 14.77 | 25.0 | 71.1 | -3.64 |
| 2025-03-25 | QURE | 14.36 | 25.0 | 87.0 | -3.64 |
| 2025-03-26 | QURE | 13.65 | 25.0 | 90.2 | -3.64 |
| 2025-03-27 | QURE | 13.13 | 25.0 | 88.7 | -3.64 |
| 2025-03-28 | QURE | 12.47 | 25.0 | 90.8 | -3.64 |
| 2025-03-31 | QURE | 10.60 | 25.0 | 107.4 | -3.64 |
| 2025-04-01 | QURE | 9.91 | 25.0 | 70.8 | -3.72 |
| 2025-04-02 | QURE | 10.62 | 25.0 | 34.8 | -3.71 |
| 2025-04-03 | QURE | 9.75 | 25.0 | 74.6 | -3.71 |
| 2025-04-04 | QURE | 8.94 | 23.9 | 77.1 | -3.71 |
| 2025-04-07 | QURE | 8.76 | 23.9 | 61.1 | -3.71 |
| 2025-04-08 | QURE | 8.34 | 23.9 | 70.0 | -3.71 |
| 2025-04-09 | QURE | 9.16 | 23.9 | 18.2 | -3.71 |
| 2025-04-10 | QURE | 8.56 | 23.9 | 74.5 | -3.71 |
| 2025-04-11 | QURE | 8.92 | 23.9 | 40.0 | -3.71 |
| 2025-04-14 | QURE | 9.17 | 23.9 | 45.9 | -3.71 |
| 2025-04-15 | QURE | 9.65 | 23.9 | 38.4 | -3.71 |
| 2025-04-16 | QURE | 9.42 | 23.9 | 61.0 | -3.71 |
| 2025-04-17 | QURE | 13.00 | 23.9 | -58.4 | -3.71 |
| 2025-04-18 | QURE | 13.00 | 23.9 | 54.2 | -3.66 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | QURE | -2.89 | 7.89 | 5.43 |
| 2025-03-24 | QURE | -4.25 | 7.90 | 5.19 |
| 2025-03-25 | QURE | -4.25 | 7.90 | 5.19 |
| 2025-03-26 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-03-27 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-03-28 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-03-31 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-04-01 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-04-02 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-04-03 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-04-04 | QURE | -4.25 | 7.90 | 6.16 |
| 2025-04-07 | QURE | -4.25 | 7.91 | 6.16 |
| 2025-04-08 | QURE | -4.25 | 7.91 | 6.16 |
| 2025-04-09 | QURE | -4.25 | 7.91 | 6.16 |
| 2025-04-10 | QURE | -4.25 | 7.91 | 8.88 |
| 2025-04-11 | QURE | -4.25 | 7.91 | 8.88 |
| 2025-04-14 | QURE | -4.25 | 7.92 | 8.88 |
| 2025-04-15 | QURE | -4.25 | 7.92 | 8.88 |
| 2025-04-16 | QURE | -4.25 | 7.92 | 8.88 |
| 2025-04-17 | QURE | -4.25 | 7.92 | 8.88 |
| 2025-04-18 | QURE | -4.25 | 7.92 | 8.88 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.5
Avg. EPS Est. Current Quarter
-0.97
Avg. EPS Est. Next Quarter
-0.97
Insider Transactions
-4.25
Institutional Transactions
7.92
Beta
0.21
Average Sales Estimate Current Quarter
5
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
19
Growth Score
46
Sentiment Score
91
Actual DrawDown %
81.8
Max Drawdown 5-Year %
-94.4
Target Price
35.17
P/E
Forward P/E
PEG
P/S
25.92
P/B
P/Free Cash Flow
EPS
-4.92
Average EPS Est. Cur. Y
-3.66
EPS Next Y. (Est.)
-2.84
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-883.35
Relative Volume
13.15
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
EPS 1 30Days Diff
0.08
EBIT Estimation
54.2
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 209
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading